Document
IPR2017-01357, No. 9 Objection - Patent Owners Objections to Evidence (P.T.A.B. Dec. 15, 2017)
Cite Document
IPR2017-01357, No. 9 Objection - Patent Owners Objections to Evidence (P.T.A.B. Dec. 15, 2017)
+ More Snippets
Document
IPR2017-01357, No. 6 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Sep. 5, 2017)
Cite Document
IPR2017-01357, No. 6 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Sep. 5, 2017)
+ More Snippets
Document
IPR2017-01357, No. 5 Mandatory Notice - Patent Owner Mandatory Notice (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2017-01357, No. 5 Mandatory Notice - Patent Owner Mandatory Notice (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2017-01357, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2017-01357, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2017-01357, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. May. 19, 2017)
Cite Document
IPR2017-01357, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. May. 19, 2017)
+ More Snippets
Document
IPR2017-01357, No. 2307-81 Exhibit - EX2307 Winters (P.T.A.B. Jul. 5, 2018)
Cite Document
IPR2017-01357, No. 2307-81 Exhibit - EX2307 Winters (P.T.A.B. Jul. 5, 2018)
+ More Snippets
Document
IPR2017-01357, No. 2302-76 Exhibit - EX2302 Wieland (P.T.A.B. Jul. 5, 2018)
Cite Document
IPR2017-01357, No. 2302-76 Exhibit - EX2302 Wieland (P.T.A.B. Jul. 5, 2018)
+ More Snippets
Document
IPR2017-01357, No. 2204-71 Exhibit - EX2204 Fuller (P.T.A.B. Jun. 19, 2018)
Cite Document
IPR2017-01357, No. 2204-71 Exhibit - EX2204 Fuller (P.T.A.B. Jun. 19, 2018)
+ More Snippets
Document
IPR2017-01357, No. 2203-70 Exhibit - EX2203 Markussen (P.T.A.B. Jun. 19, 2018)
Cite Document
IPR2017-01357, No. 2203-70 Exhibit - EX2203 Markussen (P.T.A.B. Jun. 19, 2018)
+ More Snippets
Document
IPR2017-01357, No. 1046-59 Exhibit - Ex 1046 Sanchayita Ghose et al, pH Transitions in Ion Exchange Systems Role in the Development of a Cation Exchange Process for a Recombinant Prot...
Cite Document
IPR2017-01357, No. 1046-59 Exhibit - Ex 1046 Sanchayita Ghose et al, pH Transitions in Ion Exchange Systems Role in the Development of a Cation Exchange Process for a Recombinant Protein, Biotechn P
+ More Snippets
Document
IPR2017-01357, No. 1045-58 Exhibit - Ex 1045 Pete Gagnon Chapter 17 Polishing Methods for Monoclonal IgG Purification, in Process Scale Bioseparations for the Biopharmaceutical Industry...
Cite Document
IPR2017-01357, No. 1045-58 Exhibit - Ex 1045 Pete Gagnon Chapter 17 Polishing Methods for Monoclonal IgG Purification, in Process Scale Bioseparations for the Biopharmaceutical Industry Abhinav A Sh
+ More Snippets
Document
IPR2017-01357, No. 1053-66 Exhibit - Ex 1053 Protocol for Citrate Buffer Conductivity Measurements prepared by Todd M Przybycien on May 8, 2017 Protocol (P.T.A.B. May. 24, 2018)
Cite Document
IPR2017-01357, No. 1053-66 Exhibit - Ex 1053 Protocol for Citrate Buffer Conductivity Measurements prepared by Todd M Przybycien on May 8, 2017 Protocol (P.T.A.B. May. 24, 2018)
+ More Snippets
Document
IPR2017-01357, No. 1027-41 Exhibit - Ex 1027 Updated Formulas and Calculations prepared by Todd M Pryzbycien in response to Dr Cramers Direct Testimony (P.T.A.B. May. 24, 2018)
Cite Document
IPR2017-01357, No. 1027-41 Exhibit - Ex 1027 Updated Formulas and Calculations prepared by Todd M Pryzbycien in response to Dr Cramers Direct Testimony (P.T.A.B. May. 24, 2018)
+ More Snippets
Document
IPR2017-01357, No. 1031-45 Exhibit - Ex 1031 Ghose et al, Binding Capacity Differences for Antibodies and Fc Fusion Proteins on Protein A Chromatographic Materials, Biotech Bioengg, 964 ...
Cite Document
IPR2017-01357, No. 1031-45 Exhibit - Ex 1031 Ghose et al, Binding Capacity Differences for Antibodies and Fc Fusion Proteins on Protein A Chromatographic Materials, Biotech Bioengg, 964 768 778 200
+ More Snippets
Document
IPR2017-01357, No. 1030-44 Exhibit - Ex 1030 Ghose et al, Antibody Variable Region Interactions with Protein AImplications for the Development of Generic Purification Processes,¿¿¿ Biotech, ...
Cite Document
IPR2017-01357, No. 1030-44 Exhibit - Ex 1030 Ghose et al, Antibody Variable Region Interactions with Protein AImplications for the Development of Generic Purification Processes,¿¿¿ Biotech, 926665 6
+ More Snippets